Endocarditis due to glycopeptide-intermediate Staphylococcus aureus: case report and strain characterization

Date
2003-02-01Author
Andrade-Baiocchi, S.
Tognim, MCB
Baiocchi, Otavio Carvalho Guimarães [UNIFESP]
Sader, H. S.
Type
ArtigoISSN
0732-8893Is part of
Diagnostic Microbiology and Infectious DiseaseDOI
10.1016/S0732-8893(02)00511-4Metadata
Show full item recordAbstract
We report a case of infective endocarditis due to vancomycin-intermediate Staphylococcus aureus (VISA) that did not respond to high doses of vancomycin. Initial vancomycin MIC of the last isolate recovered from blood was 8 1 mug/mL, but could be induced up to 32 mug/mL by consecutive growing with vancomycin. Clinical response was only accomplished when linezolid was included in therapy. (C) 2003 Elsevier Science Inc. All rights reserved.
Citation
Diagnostic Microbiology and Infectious Disease. New York: Elsevier B.V., v. 45, n. 2, p. 149-152, 2003.Keywords
vancomycin-intermediate Staphylococcus aureusvancomycin resistance
VISA
GISA
endocarditis
multiple myeloma
linezolid
Collections
- EPM - Artigos [17701]